Open science: The key to maximizing the impact of neuroimaging research

Open science and information sharing on a medical specialty-wide scale are the cornerstones of community-based research efforts such as neuroimaging, according to Cameron Craddock, PhD, of the Nathan S. Kline Institute for Psychiatric Research.

“The principles of open science have permeated neuroimaging to the point that nearly every software tool produced is free and open source and most new neuroimaging datasets are earmarked for data sharing,” Craddock wrote in a guest blog post for Biomed Central. “As these open science resources continue to blossom it is important to reflect on the importance of community-based efforts to nurture these resources so that they maintain their relevance well into the future.”

Craddock says ongoing efforts related to database creation, literature curations, data inspection, preprocessing and open source software are needed to further advance the collaborative nature of neuroimaging.

Read the full article at the link below.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.